Vinayak S. Doraiswamy - 20 May 2021 Form 3 Insider Report for AtriCure, Inc. (ATRC)

Role
Chief Scientific Officer
Signature
/s/ Vinayak Doraiswamy
Issuer symbol
ATRC
Transactions as of
20 May 2021
Net transactions value
$0
Form type
3
Filing time
24 May 2021, 17:31:46 UTC
Next filing
02 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATRC Common Stock 24,119 20 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 15,568 shares of unvested restricted stock awarded under the AtriCure, Inc. 2014 Equity Incentive Plan. One third of the shares vest annually upon the respective one, two and three year anniversaries of the date of grant. Includes 879 shares acquired under the AtriCure, Inc. Employee Stock Purchase Plan.